APOLLO ENDOSURGERY INC (APEN)
US03767D1081 - Common Stock
We assign a fundamental rating of 1 out of 10 to APEN. APEN was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of APEN have multiple concerns. While showing a medium growth rate, APEN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
APEN had negative earnings in the past year.
APEN had a negative operating cash flow in the past year.
In the past 5 years APEN always reported negative net income.
APEN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
APEN has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
APEN has a Gross Margin (55.20%) which is in line with its industry peers.
In the last couple of years the Gross Margin of APEN has declined.
The Profit Margin and Operating Margin are not available for APEN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5Y-2.23%
2. Health
2.1 Basic Checks
APEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
APEN has more shares outstanding than it did 1 year ago.
APEN has more shares outstanding than it did 5 years ago.
APEN has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -0.16, we must say that APEN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.16, APEN is doing worse than 60.56% of the companies in the same industry.
APEN has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of APEN (1.04) is worse than 79.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.16 |
ROIC/WACCN/A
WACC10.2%
2.3 Liquidity
APEN has a Current Ratio of 2.35. This indicates that APEN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of APEN (2.35) is worse than 66.20% of its industry peers.
APEN has a Quick Ratio of 1.89. This is a normal value and indicates that APEN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of APEN (1.89) is worse than 60.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
The earnings per share for APEN have decreased by -9.99% in the last year.
The Revenue has grown by 22.01% in the past year. This is a very strong growth!
APEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.63% yearly.
EPS 1Y (TTM)-9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.21%
Revenue 1Y (TTM)22.01%
Revenue growth 3Y14.87%
Revenue growth 5Y3.63%
Sales Q2Q%31.8%
3.2 Future
The Earnings Per Share is expected to grow by 11.79% on average over the next years. This is quite good.
Based on estimates for the next years, APEN will show a very strong growth in Revenue. The Revenue will grow by 33.84% on average per year.
EPS Next Y13.1%
EPS Next 2Y11.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.29%
Revenue Next 2Y20.22%
Revenue Next 3Y33.84%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for APEN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APEN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.79%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for APEN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
APOLLO ENDOSURGERY INC
NASDAQ:APEN (4/3/2023, 8:15:00 PM)
After market: 9.99 -0.01 (-0.1%)10
+0.08 (+0.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners64.4%
Inst Owner Change-31.82%
Ins Owners25.67%
Ins Owner Change0%
Market Cap475.49M
Analysts76.36
Price Target10.2 (2%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.12%
Min EPS beat(2)-18.32%
Max EPS beat(2)-7.91%
EPS beat(4)0
Avg EPS beat(4)-11.05%
Min EPS beat(4)-18.32%
Max EPS beat(4)-4.68%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.43%
Min Revenue beat(2)5.11%
Max Revenue beat(2)5.74%
Revenue beat(4)4
Avg Revenue beat(4)4.43%
Min Revenue beat(4)3.3%
Max Revenue beat(4)5.74%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.19 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 14.59 | ||
| P/tB | 19.66 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.98
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS1.62
BVpS0.69
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.2% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5Y-2.23%
F-Score3
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 92.55% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | -0.16 |
F-Score3
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)51.5%
Cap/Depr(5y)41.93%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.21%
EPS Next Y13.1%
EPS Next 2Y11.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.01%
Revenue growth 3Y14.87%
Revenue growth 5Y3.63%
Sales Q2Q%31.8%
Revenue Next Year18.29%
Revenue Next 2Y20.22%
Revenue Next 3Y33.84%
Revenue Next 5YN/A
EBIT growth 1Y-44.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-116.29%
OCF growth 3YN/A
OCF growth 5YN/A